• Tranexamic Acid Workflows for Clot Research

  2026-09-04

  Build reproducible fibrinolysis and clot-stability experiments with Tranexamic Acid, from plasmin inhibition assays to biomaterial screening. This workflow translates a 2024 composite wound-dressing study into practical concentration control, readout selection, and troubleshooting decisions.

• NSP15 Screening Identifies Thymopentin and Oleuropein

  2026-09-03

  A 2021 structure-based study screened a natural-product library against the SARS-CoV-2 endoribonuclease NSP15 and identified thymopentin and oleuropein as leading computational inhibitors. Molecular-dynamics analysis supported stable protein–ligand complexes, but biochemical and cellular validation remains necessary before these candidates can be considered antiviral interventions.

• POx-Lipid LNPs as PEG Alternatives for mRNA

  2026-09-02

  Holick and colleagues investigated poly(2-ethyl-2-oxazoline)-based lipids as substitutes for PEG-lipids in mRNA lipid nanoparticles. By varying polymer chain length and combining physicochemical, immunological, transfection, and super-resolution imaging analyses, the study identified a PEtOx-LNP formulation that outperformed the commercial PEG-lipid benchmark used in Comirnaty.

• Cyanine 3 Tyramide for Neural Signal Mapping

  2026-09-02

  Cyanine 3 Tyramide combines orange fluorescence with enzyme-driven deposition to reveal low-abundance molecular signals in tissue, cells, and spatial neuroscience assays. This guide connects practical TSA workflows with the early-life-adversity and oxytocin findings reported in a recent mouse study, while emphasizing validation, multiplexing, and troubleshooting.

• Exemestane: From Aromatase Mechanism to Translation

  2026-09-02

  A mechanism-first guide to using Exemestane in breast cancer research, from irreversible aromatase inactivation and assay design to biomarker-aware translational strategy.

• Genistein and Mechanostress: Better Cancer Assays

  2026-09-01

  Genistein can help connect growth-factor signaling, cell proliferation inhibition, and cancer chemoprevention studies with emerging mechanotransduction research. This guide explains how to use it as a controlled perturbation without confusing kinase effects with cytoskeleton-dependent autophagy.

• EZ Cap EGFP mRNA 5-moUTP: Delivery Guide

  2026-08-31

  EZ Cap EGFP mRNA 5-moUTP is more than a fluorescent reporter: it is a controlled probe for separating transcript quality, delivery, translation, and cellular response. This guide connects its Cap1, 5-moUTP, and poly(A) design with hybrid nanoparticle evidence to improve assay interpretation from cultured cells to in vivo imaging.

• Y-27632: Practical ROCK Inhibitor Workflow

  2026-08-31

  Y-27632 provides a reversible, ATP-competitive approach for testing ROCK1 and ROCK2 involvement in cytoskeletal organization and cell-based assays. This guide covers dossier-supported handling and workflow recommendations, but it should not be treated as clinical guidance or as evidence for outcomes in models lacking directly matched literature.

• Ginsenoside Rg6 and Cisplatin Resistance in Ovarian Cancer

  2026-08-30

  The reference study identifies a mechanistic link between aberrant fucosylation, the GRB2–ERK1/2–mTOR axis, autophagy, and cisplatin resistance in epithelial ovarian cancer cells. Its findings suggest that ginsenoside Rg6 may restore cisplatin sensitivity by promoting autophagy, reducing CTR1 core fucosylation, and increasing intracellular cisplatin uptake, although the evidence remains preclinical.

• AMG 487 CXCR3 Antagonist Workflow

  2026-08-29

  AMG 487 enables ligand-specific CXCR3 pathway dissection across calcium flux, chemotaxis, macrophage polarization, and autophagy assays. Its strongest use-case is state-aware experimentation, where inflammatory and non-inflammatory macrophages can respond differently to the same CXCL10–CXCR3 perturbation.

• Bovine Insulin for Metabolic Cell Culture Assays

  2026-08-28

  Bovine insulin supports reproducible cell expansion while providing a controllable variable for glucose metabolism regulation and pathway-focused assays. This guide translates melanoma metabolism findings into practical workflows for dosing, ROS and PDH readouts, assay controls, and troubleshooting.

• FUS–SMN Phase Separation in Neuronal Granules

  2026-08-28

  Wang and Li show that asymmetric arginine dimethylation enables FUS to engage the oligomeric Tudor-domain protein SMN, increasing multivalent interactions and promoting phase separation. The study connects this molecular mechanism to neuronal granule formation, axonal mRNA distribution, and defects associated with reduced SMN valency in spinal muscular atrophy.

• MK 0893: Glucagon Receptor Antagonist Mechanism

  2026-08-28

  MK 0893 is a competitive, reversible glucagon receptor antagonist that blocks human GCGR signaling through an extra-helical allosteric pocket. Nanomolar binding and cAMP inhibition make it a useful tool for type 2 diabetes research, while its receptor selectivity and formulation limits require controlled assay design.

• Acridine Orange hydrochloride: Practical Guide

  2026-08-27

  Acridine Orange hydrochloride provides membrane-permeable, differential fluorescence for examining nucleic-acid-associated signals in cells. It is suitable for fresh cytochemical workflows, cell cycle analysis, apoptosis detection, and flow-based DNA/RNA assessment, but it should not be treated as a sequence-specific probe or stored long-term as a solution.

• Methyl-β-cyclodextrin: Membrane Study Workflow

  2026-08-26

  Methyl-β-cyclodextrin (MβCD) is used to extract cholesterol and other hydrophobic lipids from biological membranes, enabling controlled studies of membrane organization, fluidity, and lipid-dependent signaling. It is intended for research workflows only, not diagnostic or medical use, and requires fresh solution handling and matched controls for reproducible interpretation.

553 records 6/37 page Previous Next First page 上5页 678910 下5页 Last page